Gland Pharma Limited CC-Dec24.pdf · 2025-02-03
I just wanted to understand, going forward, if Enoxa volumes were to higher, right, one, because of like Chinese competition abating a bit because of tariffs; and two, particularly in this quarter, I guess, you have some slippage coming from the previous quarter. So, should one think that volume growth would be very high, or margins will take a knock? How should one think about this?
Understood. With respect to Cenexi business, last we spoke, you mentioned RFPs are coming quick and fast. Can you just talk a little bit about that.